Basic Information | Post buying leads | Suppliers |
Name |
Eritoran |
EINECS | N/A |
CAS No. | 185955-34-4 | Density | 1.14g/cm3 |
PSA | 324.57000 | LogP | 16.14580 |
Solubility | N/A | Melting Point |
N/A |
Formula | C66H126N2O19P2 | Boiling Point | N/A |
Molecular Weight | 1313.66 | Flash Point | N/A |
Transport Information | N/A | Appearance | N/A |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
a-D-Glucopyranose,3-O-decyl-2-deoxy-6-O-[2-deoxy-3-O-[(3R)-3-methoxydecyl]-6-O-methyl-2-[[(11Z)-1-oxo-11-octadecen-1-yl]amino]-4-O-phosphono-b-D-glucopyranosyl]-2-[(1,3-dioxotetradecyl)amino]-,1-(dihydrogen phosphate); |
1. Introduction of Eritoran
Eritoran, with the systematic name of [(2R,3R,4R,5S,6R)-4-decoxy-5-hydroxy-6-[[(2R,3R,4R,5S,6R)-4-[(3R)-3-methoxydecoxy]-6-(methoxymethyl)-3-[[(Z)-octadec-11-enoyl]amino]-5-phosphonooxyoxan-2-yl]oxymethyl]-3-(3-oxotetradecanoylamino)oxan-2-yl] dihydrogen phosphate, is one kind of medicine. Eritoran is an investigational drug for the treatment of severe sepsis, an excessive inflammatory response to an infection.
2. Properties of Eritoran
Physical properties about Eritoran are: (1)ACD/LogP: 17.81; (2)# of Rule of 5 Violations: 4; (3)ACD/LogD (pH 5.5): 13.2; (4)ACD/LogD (pH 7.4): 11.69; (5)ACD/BCF (pH 5.5): 1000000; (6)ACD/BCF (pH 7.4): 1000000; (7)ACD/KOC (pH 5.5): 2908118.25; (8)ACD/KOC (pH 7.4): 88986.11; (9)#H bond acceptors: 21; (10)#H bond donors: 7; (11)#Freely Rotating Bonds: 60; (12)Polar Surface Area: 284.67Å2.
3. Structure Descriptors of Eritoran
You could convert the following datas into the molecular structure:
1).SMILES: [Na+].[Na+].[Na+].[Na+].O=P([O-])([O-])O[C@H]1O[C@@H]([C@@H](O)[C@H](OCCCCCCCCCC)[C@H]1NC(=O)CC(=O)CCCCCCCCCCC)CO[C@@H]2O[C@H](COC)[C@@H](OP([O-])([O-])=O)[C@H](OCC[C@H](OC)CCCCCCC)[C@H]2NC(=O)CCCCCCC CC\C=C/CCCCCC
2).InChI: InChI=1/C66H126N2O19P2.4Na/c1-7-11-15-19-22-25-26-27-28-29-30-32-34-38-42-46-57(70)67-60-64(82-49-47-54(80-6)45-41-36-18-14-10-4)62(86-88(73,74)75)56(51-79-5)85-65(60)83-52-55-61(72)63(81-48-43-39-35-24-21-17-13-9-3)59(66(84-55)87-89(76,77)78)68-58(71)50-53(69)44-40-37-33-31-23-20-16-12-8-2;;;;/h25-26,54-56,59-66,72H,7-24,27-52H2,1-6H3,(H,67,70)(H,68,71)(H2,73,74,75)(H2,76,77,78);;;;/q;4*+1/p-4/b26-25-;;;;/t54-,55-,56-,59-,60-,61-,62-,63-,64-,65-,66-;;;;/m1..../s1
3).InChIKey: FEMINZOAAWPBPP-SDFKCJNWBN
4).Std. InChI: InChI=1S/C66H126N2O19P2.4Na/c1-7-11-15-19-22-25-26-27-28-29-30-32-34-38-42-46-57(70)67-60-64(82-49-47-54(80-6)45-41-36-18-14-10-4)62(86-88(73,74)75)56(51-79-5)85-65(60)83-52-55-61(72)63(81-48-43-39-35-24-21-17-13-9-3)59(66(84-55)87-89(76,77)78)68-58(71)50-53(69)44-40-37-33-31-23-20-16-12-8-2;;;;/h25-26,54-56,59-66,72H,7-24,27-52H2,1-6H3,(H,67,70)(H,68,71)(H2,73,74,75)(H2,76,77,78);;;;/q;4*+1/p-4/b26-25-;;;;/t54-,55-,56-,59-,60-,61-,62-,63-,64-,65-,66-;;;;/m1..../s1